Stemming the tide

• Autores: Andy Coghlan
• Localización: New scientist, ISSN 0262-4079, Nº. 3161, 2018, págs. 22-23
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Coghlan asks whether is it too late to crack down if a mix of medical ambiguity and libertarian laws has fuelled untested stem cell treatments. The first known death from a stem cell treatment and others in which unsuspecting people have been harmed authorities in the US and Australia are introducing new measures to crack down on unregulated stem cell clinics, while supporting those developing legitimate treatments. Stem cells hold great promise because they have the potential to mature into and repair multiple tissues of the body. But in the past few years, hundreds of clinics have sprung up offering stem cell treatments that haven't been thoroughly tested in clinical trials or approved by regulators. Three factors have driven the rise of private stem cell clinics in the US and Australia include ambiguity, past lax scrutiny of the field by regulatory authorities and growth in the US of laws that entitle people to try untested treatments